ACE2 alterations in kidney disease

Role of Circulating Angiotensin Converting Enzyme 2 in Left Ventricular Remodeling following Myocardial Infarction: A Prospective Controlled Study

(2013) José T. Ortiz-Pérez et al.   PLoS One

Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

(2013) Harshita Chodavarapu et al.   PLoS One

High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria

(2012) Se Eun Park et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats

(2012) Jennifer Lo et al.   EXPERIMENTAL PHYSIOLOGY

Murine Recombinant Angiotensin-Converting Enzyme 2

(2012) Minghao Ye et al.   HYPERTENSION

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

(2012) Renisha Nadarajah et al.   KIDNEY INTERNATIONAL

Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy

(2012) Zhen Liu et al.   LABORATORY INVESTIGATION

Role of angiotensin-converting enzyme (ACE and ACE2) imbalance on tourniquet-induced remote kidney injury in a mouse hindlimb ischemia–reperfusion model

(2012) Xiu-hong Yang et al.   PEPTIDES

Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes

(2012) Fengxia Xiao et al.   PLoS One

Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition

(2011) L. M. Burrell et al.   EXPERIMENTAL PHYSIOLOGY

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications

(2011) Aino Soro-Paavonen et al.   JOURNAL OF HYPERTENSION

Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy

(2011) Daniel Batlle et al.   KIDNEY INTERNATIONAL

High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage

(2011) Stella Bernardi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study

(2011) Alberto Martínez-Castelao et al.   BMC Nephrology

Aldosterone-induced kidney injury is mediated by NFκB activation

(2010) Seiichi Fukuda et al.   Clinical and Experimental Nephrology

ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats

(2010) Kátia D. da Silveira et al.   CLINICAL SCIENCE

Urocanic acid as an efficient hydroxyl radical scavenger: a quantum theoretical study

(2010) Saumya Tiwari et al.   JOURNAL OF MOLECULAR MODELING

Increased ACE and Decreased ACE2 Expression in Kidneys from Patients with IgA Nephropathy

(2010) Sonoo Mizuiri et al.   NEPHRON CLINICAL PRACTICE

Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia

(2009) Hong Peng Jia et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition

(2009) Elena Velkoska et al.   CLINICAL SCIENCE

New aspects of the renin–angiotensin system: angiotensin-converting enzyme 2 – a potential target for treatment of hypertension and diabetic nephropathy

(2009) Daniel Batlle et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

(2009) G. Y. Oudit et al.   DIABETES

Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2

(2009) Jan Wysocki et al.   HYPERTENSION

Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes

(2009) Slava Epelman et al.   JOURNAL OF CARDIAC FAILURE

Genetic deletion of the angiotensin-(1–7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria

(2009) Sérgio V.B. Pinheiro et al.   KIDNEY INTERNATIONAL

Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation

(2009) Vanesa Esteban et al.   PLoS One

Expression of ACE and ACE2 in Individuals With Diabetic Kidney Disease and Healthy Controls

(2008) Sonoo Mizuiri et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes

(2008) C. Tikellis et al.   DIABETES

Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy

(2008) G. Wang et al.   DIABETOLOGIA

Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor

(2008) Rebecca A. Lew et al.   EXPERIMENTAL PHYSIOLOGY

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

(2008) Heather N. Reich et al.   KIDNEY INTERNATIONAL

Renal ACE and ACE2 Expression in Early Diabetic Rats

(2008) Ju-Young Moon et al.   NEPHRON EXPERIMENTAL NEPHROLOGY

Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats

(2008) David J. Leehey et al.   Translational Research